WO2004037226B1 - Compositions pharmaceutiques renfermant de la venlafaxine - Google Patents
Compositions pharmaceutiques renfermant de la venlafaxineInfo
- Publication number
- WO2004037226B1 WO2004037226B1 PCT/IL2003/000862 IL0300862W WO2004037226B1 WO 2004037226 B1 WO2004037226 B1 WO 2004037226B1 IL 0300862 W IL0300862 W IL 0300862W WO 2004037226 B1 WO2004037226 B1 WO 2004037226B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- core
- venlafaxine
- outer coating
- water
- burst
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/532,407 US20060057204A1 (en) | 2002-10-25 | 2003-10-23 | Pharmaceutical compositions containing venlafaxine |
CA002503380A CA2503380A1 (fr) | 2002-10-25 | 2003-10-23 | Compositions pharmaceutiques renfermant de la venlafaxine |
EP03758627A EP1558222A2 (fr) | 2002-10-25 | 2003-10-23 | Compositions pharmaceutiques renfermant de la venlafaxine |
AU2003274655A AU2003274655A1 (en) | 2002-10-25 | 2003-10-23 | Pharmaceutical compositions containing venlafaxine |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/280,084 US6703044B1 (en) | 2002-10-25 | 2002-10-25 | Venlafaxine formulations |
US10/280,084 | 2002-10-25 | ||
IL158,493 | 2003-10-20 | ||
IL15849303A IL158493A0 (en) | 2002-10-25 | 2003-10-20 | Pharmaceutical compositions containing venlafaxine |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004037226A2 WO2004037226A2 (fr) | 2004-05-06 |
WO2004037226A3 WO2004037226A3 (fr) | 2004-07-08 |
WO2004037226B1 true WO2004037226B1 (fr) | 2004-09-10 |
Family
ID=32178938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2003/000862 WO2004037226A2 (fr) | 2002-10-25 | 2003-10-23 | Compositions pharmaceutiques renfermant de la venlafaxine |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1558222A2 (fr) |
AU (1) | AU2003274655A1 (fr) |
CA (1) | CA2503380A1 (fr) |
WO (1) | WO2004037226A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007520547A (ja) * | 2004-02-04 | 2007-07-26 | アレムビック・リミテッド | ベンラファキシン塩酸塩の徐放性コーティングされた小型錠剤 |
US20090175934A1 (en) * | 2006-03-08 | 2009-07-09 | Jubilant Organosys Ltd. | Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same |
WO2007112574A1 (fr) * | 2006-04-03 | 2007-10-11 | Isa Odidi | Composition de venlafaxine à libération prolongée |
US9381248B2 (en) * | 2010-08-31 | 2016-07-05 | Toray Industries, Inc. | Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
EP1474123A1 (fr) * | 2002-01-03 | 2004-11-10 | LEK Pharmaceuticals D.D. | Formulation pharmaceutique a liberation controlee contenant de la venlafaxine |
-
2003
- 2003-10-23 EP EP03758627A patent/EP1558222A2/fr not_active Withdrawn
- 2003-10-23 WO PCT/IL2003/000862 patent/WO2004037226A2/fr not_active Application Discontinuation
- 2003-10-23 AU AU2003274655A patent/AU2003274655A1/en not_active Abandoned
- 2003-10-23 CA CA002503380A patent/CA2503380A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004037226A3 (fr) | 2004-07-08 |
EP1558222A2 (fr) | 2005-08-03 |
AU2003274655A8 (en) | 2004-05-13 |
AU2003274655A1 (en) | 2004-05-13 |
WO2004037226A2 (fr) | 2004-05-06 |
CA2503380A1 (fr) | 2004-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268722B2 (en) | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | |
CA2446712C (fr) | Systeme d'administration osmotique d'agents pharmaceutiquement actifs | |
AU733801B2 (en) | Multiple unit effervescent dosage form | |
ES2355099T3 (es) | Dispositivo osmótico dentro de un dispositivo osmótico. | |
KR101834033B1 (ko) | 주의력 결핍 장애 치료용 고체 경구 제약 조성물 | |
JP5572616B2 (ja) | 口腔内分散性多層錠剤 | |
RU2314810C2 (ru) | Способ лечения с использованием лекарственных форм, содержащих фармацевтические композиции 5,8,14-триазатетрацикло[10.3.1.0 (2,11).0(4,9)] гексадека-2( 11),3,5,7,9-пентаена | |
EP1909770B1 (fr) | Composition a liberation orale controlee contenant du levetiracetam | |
WO2007000778A3 (fr) | Compositions pharmaceutiques a liberation modifiee et leurs procedes | |
IL211075A (en) | Multi-component preparation with irregular release | |
CA2126611A1 (fr) | Formulations d'opioides a liberation prolongee | |
CA2434484A1 (fr) | Compositions comprenant de l'ibuprofene et de la diphehydramine destinees a traiter les troubles du sommeil lies a la douleur | |
AU2002303897A1 (en) | System for osmotic delivery of pharmaceutically active agents | |
CA2628200A1 (fr) | Compositions pharmaceutiques solides contenant de la pregabaline | |
US6080427A (en) | Cefadroxil monohydrate tablet formulation | |
CA2330480A1 (fr) | Preparation a liberation controlee de divalproex sodium | |
SG146638A1 (en) | Pharmaceutical delivery system | |
JP2002530322A5 (fr) | ||
JP2005528430A5 (fr) | ||
NZ514129A (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
EP1679066A1 (fr) | Microparticule enrobee contenant un medicament pour comprime a dissolution orale | |
WO2004037226B1 (fr) | Compositions pharmaceutiques renfermant de la venlafaxine | |
MXPA04009906A (es) | Composiciones farmaceuticas de liberacion controlada de carbipoda y levopoda. | |
RU2002109236A (ru) | Композиции с контрлируемым высвобождением для перорального применения | |
JPS62142113A (ja) | 口腔粘膜付着用錠剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
B | Later publication of amended claims |
Effective date: 20040726 |
|
ENP | Entry into the national phase |
Ref document number: 2006057204 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2503380 Country of ref document: CA Ref document number: 10532407 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003758627 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003758627 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10532407 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |